标题 |
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial
|
网址 | |
DOI | |
其它 |
期刊:The Lancet Infectious Diseases 作者:Jun-Dong Wu; Jing-Xin Li; Jian Liu; Hao-Meng Wang; Guang-Hui Zhou; et al 出版日期:2023 |
求助人 | |
下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |